Improvement of myocardial blood flow to ischemic regions by angiotensin- converting enzyme inhibition with quinaprilat IV: A study using [15O] water dobutamine stress positron emission tomography

Journal of the American College of Cardiology

Volumn 34, Issue 4, 1999, Pages 1005-1011

  Schneider, Christian A ^c   Voth, Eberhard ^d   Moka, Detlef ^d   Baer, Frank M ^d   Melin, Jacques ^a   Bol, Anne ^a   Wagner, Rainer ^b   Schicha, Harald ^d   Erdmann, Erland ^d   Sechtem, Udo ^d  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b MAX PLANCK INSTITUTE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; QUINAPRILAT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; DRUG EFFECT; EXERCISE TEST; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART RATE; HEART STRESS; HEART VENTRICLE PRESSURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; CORONARY CIRCULATION; CORONARY DISEASE; DOBUTAMINE; EXERCISE TEST; FEMALE; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TETRAHYDROISOQUINOLINES; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 0033213368     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00316-2     Document Type: Article

References (31)

1. Sudhir K., Chou T.M., Hutchison S.J., Chatterjee K. Coronary vasodilation by angiotensin-converting enzyme inhibition in vivo. Circulation. 93:1996;1734-1739.
2. Kitakaze M., Minamino T., Node K., et al. Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs. Circulation. 92:1995;950-961.
3. Ertl G., Kloner R.A., Alexander R.W., Braunwald E. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation. 65:1982;40-48.
4. Piana R.N., Wang S.Y., Friedmann M., Selke F.W. Angiotensin-converting enzyme inhibition preserves endothelium-dependent coronary microvascular responses during short-term ischemia-reperfusion. Circulation. 93:1996;544-551.
5. Ikram H., Low C.J.S., Shirlaw T., et al. Antianginal, hemodynamic and coronary vascular effects of captopril in stable angina pectoris. Am J Cardiol. 66:1990;164-167.
6. Kiowski W., Zuber M., Elsasser S., et al. Coronary vasodilation and improved myocardial lactate metabolism after angiotensin-converting enzyme inhibition with cilazapril in patients with congestive heart failure. Am Heart J. 122:1991;1382-1388.
7. Perondi R., Saino A., Tio R.A., et al. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. Circulation. 85:1992;2004-2013.
8. Krivokapich J., Czernin J., Schelbert H.R. Dobutamine positron emission tomography absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease . J Am Coll Cardiol. 28:1996;565-572.
9. Severi S., Underwood R., Mohiaddin R.H., et al. Dobutamine stress effects on regional myocardial blood flow and wall motion . J Am Coll Cardiol. 26:1995;1187-1195.
10. de Bruyne B., Baudhuin T., Melin J.A., et al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation. 89:1994;1013-1022.
11. Wienhard K., Eriksson L., Grootoonk S., et al. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr. 16:1992;804-813.
12. Bol A., Melin J.A., Vanoverschelde J.-L., et al. Direct comparison of 13-N ammonia and 15-O water estimates of perfusion with quantification of regional blood flow by microspheres. Circulation. 87:1993;512-525.
13. Merlet P., Mazoyer B., Hittinger L., et al. Assessment of coronary reserve in men comparison between positron emission tomography with oxygen-15 labeled water and intracoronary doppler technique . J Nucl Med. 34:1993;1899-1904.
14. Uren N.G., Melin J.A., de Bruyne B., et al. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med. 330:1994;1782-1788.
15. Nelson R.H., Gobel F.L., Jorgensen C.R., et al. Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation. 50:1974;1179-1189.
16. Aickin M., Gensler H. Adjusting for multiple testing when reporting research results the Bonferroni vs Holm methods . Am J Public Health. 86:1996;726-728.
17. Nabel E.G., Selwyn A.P., Ganz P. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate. Circulation. 81:1990;850-859.
18. Hess O.M. Coronary stenosis vasoconstriction impact on myocardial ischemia . Eur Heart J. 18:1997;1853-1859.
19. Diet F., Pratt R.E., Berry G.J., et al. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation. 94:1996;2756-2767.
20. Jaski B.E., Peters C. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine. Am J Cardiol. 62:1988;63C-67C.
21. Remme W.J., Kruyssen D.A.C.M., Look M.P., et al. Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans. J Am Coll Cardiol. 23:1994;82-91.
22. Vatner S.F., Baig H. Importance of heart rate in determining the effects of sympathomimetic amines on regional myocardial function and blood flow in conscious dogs with acute myocardial ischemia. Circ Res. 45:1979;793-803.
23. Heusch G., Deussen A. The effects of cardiac sympathetic nerve stimulation on perfusion of stenotic coronary arteries in the dog. Circ Res. 53:1983;8-15.
24. Huizer T., van der Meer P., de Jong J.W. Captopril inhibits angiotensin I induced coronary flow reduction in isolated rat hearts but has no effect on contractility or energy metabolism. Eur Heart J. 13:1991;109-114.
25. Zeiher A.M., Drexler H., Wollschläger H., et al. Coronary vasomotion in response to sympathetic stimulation in humans importance of the functional integrity of the endothelium . J Am Coll Cardiol. 14:1989;1181-1190.
26. Tian R., Neubauer S., Pulzer F., et al. Angiotensin I conversion and coronary constriction by angiotensin II in ischemic and hypoxic isolated rat hearts. Eur J Pharmacol. 203:1991;71-77.
27. Rimoldi O., Pagani M.R., Piazza S., et al. Restraining effects of captopril in sympathetic excitatory responses in dogs a spectral analysis approach . Am J Physiol. 267:1994;H1608-H1618.
28. Saino A., Pomidossi G., Perondi R., et al. Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans. Circulation. 96:1997;148-153.
29. Sudhir K., MacGregor J.S., Gupta M., et al. Effect of selective angiotensin II receptor antagonism and angiotensin-converting enzyme inhibition on the coronary vasculature in vivo. Circulation. 87:1993;931-938.
30. Haeferli W.E., Linder L., Lüscher T.F. Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans. Hypertension. 30:1997;912-917.
31. Hornig B., Kohler C., Drexler H. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans. Circulation. 95:1997;1115-1118.